StockNews.com assumed coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY – Free Report) in a research report sent to investors on Tuesday. The brokerage issued a sell rating on the stock. NovaBay Pharmaceuticals Stock Performance NBY stock opened at $0.08 on Tuesday. NovaBay Pharmaceuticals has a 1 year low of $0.07 and a 1 year high […]

Related Keywords

United States , , Novabay Pharmaceuticals , Novabay Pharmaceuticals Stock Performance , Novabay Pharmaceuticals Inc , News Ratings For Novabay Pharmaceuticals Daily , Armistice Capital , Free Report , Bay Pharmaceuticals , Get Free Report , Avenova Spray , Novabay Pharmaceuticals Daily , Nyse Nby , Anby , Medical , Initiated Coverage , Stocknews Com ,